➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Moodys
Express Scripts
Boehringer Ingelheim
McKesson

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Molybdenum


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Molybdenum?

Molybdenum is an investigational drug.

There have been 6 clinical trials for Molybdenum. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Metal Metabolism, Inborn Errors, Preleukemia, and Myelodysplastic Syndromes. The leading clinical trial sponsors are Alexion Pharma GmbH, Canadian Institutes of Health Research (CIHR), and Meddoc AS.

There are twenty-six US patents protecting this investigational drug and one hundred and sixty-eight international patents.

Recent Clinical Trials for Molybdenum
TitleSponsorPhase
Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type AAlexion Pharma GmbHPhase 2/Phase 3
A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult PatientsCanadian Institutes of Health Research (CIHR)N/A
A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult PatientsCentre for Probe Development and CommercializationN/A

See all Molybdenum clinical trials

Clinical Trial Summary for Molybdenum

Top disease conditions for Molybdenum
Top clinical trial sponsors for Molybdenum

See all Molybdenum clinical trials

US Patents for Molybdenum

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Molybdenum   Start Trial Overbased additives for lubricant oils containing a molybdenum complex, process for preparing them and compositions containing the said additives Societe Nationale Elf Aquitaine (Courbevoie, FR)   Start Trial
Molybdenum   Start Trial Hydrodealkylation of C9+ aromatic compounds Phillips Petroleum Company (Bartlesville, OK)   Start Trial
Molybdenum   Start Trial Hydrodealkylation of C.sub.9 + aromatic compounds Phillips Petroleum Company (Bartlesville, OK)   Start Trial
Molybdenum   Start Trial Catalysts made from transition metal compounds and 4, 5-diphosphinoacridine-ligands Studiengesellschaft Kohle mbH (Mulheim an der Ruhr, DE)   Start Trial
Molybdenum   Start Trial 2-phenyl benzimidazole derivatives as MCP-1 antagonists Millennium Pharmaceuticals, Inc. (Cambridge, MA)   Start Trial
Molybdenum   Start Trial Image recording material and planographic printing plate using same Fuji Photo Film Co., Ltd. (Minami-Ashigara, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Molybdenum

Drugname Country Document Number Estimated Expiration Related US Patent
Molybdenum Germany 69004163 2009-06-19   Start Trial
Molybdenum European Patent Office 0404650 2009-06-19   Start Trial
Molybdenum Spain 2060977 2009-06-19   Start Trial
Molybdenum France 2648473 2009-06-19   Start Trial
Molybdenum Japan 2883167 2009-06-19   Start Trial
Molybdenum Japan H0335094 2009-06-19   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Medtronic
McKesson
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.